Theralase Technologies Inc. announced that Brian C. Wilson, PhD has agreed to join the Theralase Medical and Scientific Advisory Board (MSAB). Dr. Wilson is a Senior Scientist and Head of the Applied Biophotonics group at Princess Margaret Cancer Centre, University Health Network and Professor in the Department of Medical Biophysics at the University of Toronto.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.165 CAD | -2.94% | -2.94% | -5.71% |
Apr. 24 | Theralase Technologies Inc. announced that it has received CAD 0.7502 million in funding | CI |
Apr. 05 | Theralase Technologies Inc. Receives Canadian Cancer Vaccine Patent | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.71% | 29.02M | |
-18.82% | 255M | |
-28.35% | 84.44M |
- Stock Market
- Equities
- TLT Stock
- News Theralase Technologies Inc.
- Theralase Technologies Inc. Appoints Brian C. Wilson to Theralase Medical and Scientific Advisory Board